EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

Philip J Mease, Joseph F Merola, Yoshiya Tanaka, Laure Gossec, Iain B McInnes, Christopher T Ritchlin, Robert B M Landewé, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende und 2 weitere

Rheumatology and Therapy · 2024-10 · 11 (5) · 1363-1382

DOI: 10.1007/s40744-024-00708-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology and Therapy, online erschienen am 31.08.2024. Verfasst von Philip J Mease und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Providence-Swedish Medical Center and University of Washington, Seattle, WA, USA. pmease@philipmease.com. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: UCB Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BimekizumabEfficacyPsoriatic arthritisSafetyTNFi-‍inadequate respondersbDMARD-naïve

Autor:innen und Institutionen

  • Department of Rheumatology, Providence-Swedish Medical Center and University of Washington, Seattle, WA, USA. pmease@philipmease.com.
  • Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
  • The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Rheumatology Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Förderung

  • UCB Pharma

Zitieren

APA

Mease, P. J., Merola, J. F., Tanaka, Y., Gossec, L., McInnes, I. B., Ritchlin, C. T., Landewé, R. B. M., Asahina, A., Ink, B., Heinrichs, A., Bajracharya, R., Shende, V., Coarse, J., & Coates, L. C. (2024). Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies. Rheumatology and Therapy, 11(5), 1363-1382. https://doi.org/10.1007/s40744-024-00708-8

Vancouver

Mease PJ, Merola JF, Tanaka Y, Gossec L, McInnes IB, Ritchlin CT, et al. Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies. Rheumatology and Therapy. 2024;11(5):1363-1382. doi:10.1007/s40744-024-00708-8

BibTeX
@article{Mease2024,
  author = {Mease, Philip J and Merola, Joseph F and Tanaka, Yoshiya and Gossec, Laure and McInnes, Iain B and Ritchlin, Christopher T and Landewé, Robert B M and Asahina, Akihiko and Ink, Barbara and Heinrichs, Andrea and Bajracharya, Rajan and Shende, Vishvesh and Coarse, Jason and Coates, Laura C},
  title = {Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies},
  journal = {Rheumatology and Therapy},
  year = {2024},
  volume = {11},
  number = {5},
  pages = {1363--1382},
  doi = {10.1007/s40744-024-00708-8}
}
Kostenlos starten →